200140 1..5Prenatal Diagnosis of Arhinia Gregory E. Zemtsov Q2Q2 Q2, MD1 Anthony E. Swartz, BS, RT(R), RDMS1 Jeffrey A. Kuller, MD1 1Department of Obstetrics and Gynecology,

A Rare Case of Congenital Arhinia Sheila Marie L. Abaygar, MD 1, Kristin Grace H. Guerrero - Gonzalez, MD 1 ABSTRACT Congenital arhinia refers to the partial or complete

Bosma Arhinia Microphthalmia and Cardiac Abnormalities: A Case ReportTrivedi et al. Clin Med Rev Case Rep 2020, 7:311 Volume 7 | Issue 5 DOI: 10.23937/2378-3656/1410311 Accepted:

De novo mutations in SMCHD1 cause Bosma arhinia microphthalmia syndrome and abrogate nasal developmentSubmitted on 8 Jan 2018 HAL is a multi-disciplinary open access archive

Bosma arhinia microphthalmia syndromeBosma arhinia microphthalmia syndrome Bosma arhinia microphthalmia syndrome (BAMS) is a rare condition characterized by abnormalities

David Cohen and Kalman Goitein, Jerusalem, Israel INTRODUCTION Among the various types of congenital malformations of the nose, complete absence of the nose is rare (Liftoff,

77409219MS ID# NEUROLOGY/2018/875146 1 FSHD type 2 and Bosma arhinia microphthalmia syndrome: two faces of 2 the same mutation 3 4 Authors: *Karlien Mul MD1, *Richard J.L.F.

Case Report GoodOutcome for an Individualwith Severe FacialAnomalies and Hypogonadotropic Hypogonadism: A Consequence of His Cognitive Function, Pragmatic Approach, and Temperament

SADJ Aug52 08.inddCASE STUDY Implant Retained Nasal Prosthesis for a Child with Congenital Arhinia - A Case Report SADJ August 2008, Vol 63 no 7 p390 - p392 I C Goossens:

Epigenetic modifier SMCHD1 maintains a normal pool of long-term hematopoietic stem cellsEpigenetic modifier SMCHD1 maintains a normal pool of long-term hematopoietic stem